Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides...
Transcript of Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides...
![Page 1: Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides under development (BNZ-1) • Scarring alopecias: low-dose naltrexone for LPP •](https://reader035.fdocuments.net/reader035/viewer/2022062415/604e92e8e59d7a3fb57b8d16/html5/thumbnails/1.jpg)
TrichologyDr. Sergio Vañó. Hospital Ramon y Cajal, Madrid
![Page 2: Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides under development (BNZ-1) • Scarring alopecias: low-dose naltrexone for LPP •](https://reader035.fdocuments.net/reader035/viewer/2022062415/604e92e8e59d7a3fb57b8d16/html5/thumbnails/2.jpg)
• Session: S023: Hair and scalp dermoscopy• Peripilar sign: Brown depressed area indicating microinflammation in AGA.
Sign of early AGA. • Specific marker of trichotillomania: flame hairs• FFA: absence of vellus hairs• FFA trichoscopic activity index: relationship between peripilar casts and
histological inflammation.
• Therapeutic hotlines (Jerry Shapiro, Wilma Bergfeld, Rod Sinclair)• AGA: oral minoxidil (safe and even better than topical), activation of Wnt
pathway (microneedling, LLLT, topical agonists – SM 04554).• Alopecia areata: JAK inhibitors (new era), preclinical studies of anti-IL 15
(BNZ-1) • Hair transplantation: endoscopic harvesting (not yet available), criticism to
“low-cost” clinics in Turkey
![Page 3: Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides under development (BNZ-1) • Scarring alopecias: low-dose naltrexone for LPP •](https://reader035.fdocuments.net/reader035/viewer/2022062415/604e92e8e59d7a3fb57b8d16/html5/thumbnails/3.jpg)
General conclusions
• Increasing interest in trichology: full rooms• Absence of lectures about frontal fibrosing alopecia• AGA: therapies with newm mechanisms, mainly activation of
Wnt pathway. Microneedling, LLLT. • Alopecia areata: JAK inhibitors, new peptides under
development (BNZ-1)• Scarring alopecias: low-dose naltrexone for LPP• Importance of trichoscopy: essential for dermatologists
interested in trichology• New lines of research: genomics, microbiome, regenerative
medicine.